Last reviewed · How we verify
NCT07139457: WESPG
Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing
NA trial testing Wearable seizure prediction and alert glasses in Epilepsy in 47 participants. Participants enrolled and being followed up; not accepting new ones.
20 October 2025
Quick facts
| Lead sponsor | Oman Ministry of Health |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 47 |
| Start date | 10 August 2025 |
| Primary completion | 20 October 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Oman |
Drugs / interventions tested
- Wearable seizure prediction and alert glasses
Conditions studied
- Epilepsy — all drugs for Epilepsy →
- Epileptic Seizures — all drugs for Epileptic Seizures →
- Focal Epilepsy — all drugs for Focal Epilepsy →
Sponsor
Oman Ministry of Health
Who can join
18 and older, any sex, with Epilepsy or Epileptic Seizures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The NEXA study aims to evaluate a new wearable EEG device designed as smart glasses with dry electrodes positioned according to the 10-20 system. The device captures real-time brain signals to detect patterns that may predict seizures, helping people with epilepsy. This study will test the device's safety, performance, and usability before seeking regulatory approval, including FDA clearance. The NEXA device is investigational and not yet approved by the U.S. FDA. The study will involve human participants who will wear the device while data is collected and analyzed. Results will help improve the device and support future certification for medical use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07139457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other Oman Ministry of Health trials
Trials by the same sponsor.
- NCT07491042 — Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients. · NA · recruiting
- NCT07413055 — Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Sur · Phase 3 · recruiting
- NCT07100717 — Intervention Study on Compassion Fatigue and Satisfaction in Omani Nurses · NA · not yet recruiting
- NCT07183982 — Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study · NA · completed
- NCT07409220 — The Use of an Audio-visual Method in Counseling for Pediatric Lumbar Puncture Procedure · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07139457 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oman Ministry of Health
- Last refreshed: 7 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07139457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing